[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-350547-105":59,"doc-detail-350547-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","lipid-dominated-metabolites-mediate-the-association-between-low-body-mass-index-and-esophageal-malignancy-a-population-based-nested-case-control-study","Lipid-dominated metabolites mediate the association between low body mass index and esophageal malignancy - a population-based nested case-control study","","Background The biological mechanism underlying the association between low body mass index (BMI) and increased risk of esophageal malignancy remains uncertain. We aimed to explore the role of metabolic alterations in the effect of low BMI on esophageal malignancy. Methods A nested case-control study used 263 cases and 263 matched controls from a high-risk community screening cohort, with untargeted metabolomic profiling on baseline serum. Results Low BMI showed a positive association with esophageal malignancy, and shared lipid-dominated mediators explained a substantial proportion of the effect. Conclusions Lipid-dominated metabolites mediate this association, supporting early-warning metabolic biomarker selection.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/lipid-dominated-metabolites-mediate-the-association-between-low-body-mass-index-and-esophageal-malignancy-a-population-based-nested-case-control-study/350547/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/lipid-dominated-metabolites-mediate-the-association-between-low-body-mass-index-and-esophageal-malignancy-a-population-based-nested-case-control-study/350547.png","ImageObject",300,407,{"name":92,"@type":93},"Ben ","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What did the study examine about low BMI and esophageal malignancy?","Question",{"text":112,"@type":113},"It investigated whether metabolic alterations mediate the association between low body mass index (BMI) and increased risk of esophageal malignancy.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was the nested case-control study designed and what samples were used?",{"text":117,"@type":113},"The study included 263 cases and 263 matched controls from a community-based screening cohort in a high-risk region. Serum samples collected at enrollment before cancer diagnosis were used for untargeted ultra-high-performance liquid chromatography-tandem mass spectrometry metabolomic profiling.",{"name":119,"@type":110,"acceptedAnswer":120},"Which metabolite mediators were identified, and what was their overall impact?",{"text":121,"@type":113},"Among 21 shared metabolites, four metabolites (three lipids and one amino acid) acted as mediators for the low BMI–esophageal malignancy association. The metabolomic signature based on these mediators explained 46.0% of the effect.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},350547,1790246563,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},2336478951081,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Liu et al. BMC Cancer (2026) 26:819 BMC Cancer  \n[https://doi.org/10.1186/s12885-026-16138-4](https://doi.org/10.1186/s12885-026-16138-4)  \nRESEARCH Open Access  \nLipid-dominated metabolites mediate the association between low body mass index and esophageal malignancy: a populationbased nested case-control study  \nMengfei Liu1†, Hongrui Tian1,2†, Minmin Wang1,3, Chuanhai Guo1, Ruiping Xu4, Fenglei Li5, Anxiang Liu6, Haijun Yang7, Liping Duan8, Lin Shen9, Qi Wu10, Zhen Liu1, Ying Liu1, Fangfang Liu1, Yaqi Pan1, Zhe Hu1, Huanyu Chen1, Hong Cai1, Zhonghu He11* and Yang Ke 11*  \nAbstract  \nBackground The biological mechanism underlying the association between low body mass index (BMI) and increased risk of esophageal malignancy remains uncertain. We aimed to explore the role of metabolic alterations in the effect of low BMI on esophageal malignancy.  \nMethods We conducted a nested case-control study using a large-scale community-based screening cohort in a high-risk region for esophageal cancer (263 cases and 263 matched controls) . Metabolomic profiling was performed based on untargeted ultra-high-performance liquid chromatography-tandem mass spectrometry, using the serum samples collected at enrollment prior to cancer diagnosis. Linear regression and conditional logistic regression were used to identify BMI-related metabolites and metabolites associated with esophageal malignancy, respectively, and the shared metabolites were included in mediation analysis.  \nResults Low BMI was positively associated with esophageal malignancy (odds ratio (OR) = 1.8 (95% confidence interval: 1.1–2. 8)) . A total of 160 metabolites were identified to be associated with low BMI, and 107 metabolites were associated with esophageal malignancy. Among the 21 shared metabolites, four metabolites (three lipids and one amino acid) were identified as mediators for the association between low BMI and esophageal malignancy, with the mediation effect (OR) of 1.1 for each mediator. The metabolic signature constructed based on these mediators could explain 46. 0% of the effect of low BMI on esophageal malignancy.  \n†Mengfei Liu and Hongrui Tian contributed equally to this work.  \n*Correspondence: Zhonghu He [zhonghuhe@foxmail.com](zhonghuhe@foxmail.com)[ ](zhonghuhe@foxmail.com)Yang Ke[keyang@bjmu.edu.cn](keyang@bjmu.edu.cn)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/licenses/by-nc-nd/4.0/](vecommons.org/licenses/by-nc-nd/4.0/.)[.](vecommons.org/licenses/by-nc-nd/4.0/.)  \nLiu et al. BMC Cancer (2026) 26:819 Page 2 of 10  \nConclusions Lipid-dominated metabolites mediate the association between low BMI and esophageal malignancy, which has provided crucial clues for understanding the etiology of esophageal malignancy and selection of earlywarning metabolic biomarkers.  \nKeywords Metabolic alteration, Esophageal cancer, Body mass index, Mediation effect  \nBackground  \nEsophageal cancer (EC), which can be mainly cl","cbCaine1URwyfGvH","https://ap.wps.com/l/cbCaine1URwyfGvH","pdf",1478763,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Keywords\n# Background\n## Esophageal cancer classifications and epidemiology\n## Risk factors and BMI associations\n## Metabolism and metabolite evidence","[{\"question\":\"What did the study examine about low BMI and esophageal malignancy?\",\"answer\":\"It investigated whether metabolic alterations mediate the association between low body mass index (BMI) and increased risk of esophageal malignancy.\"},{\"question\":\"How was the nested case-control study designed and what samples were used?\",\"answer\":\"The study included 263 cases and 263 matched controls from a community-based screening cohort in a high-risk region. Serum samples collected at enrollment before cancer diagnosis were used for untargeted ultra-high-performance liquid chromatography-tandem mass spectrometry metabolomic profiling.\"},{\"question\":\"Which metabolite mediators were identified, and what was their overall impact?\",\"answer\":\"Among 21 shared metabolites, four metabolites (three lipids and one amino acid) acted as mediators for the low BMI–esophageal malignancy association. The metabolomic signature based on these mediators explained 46.0% of the effect.\"}]","Lipid-dominated metabolites mediate the association between low body mass index and esophageal malignancy - a population-based nested case-control study | PDF",1790089538,25,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1f2480439b00da3bbe4b4dbae51835a0.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4d19d1492923dd8b6b90595f0ed4fcda.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/14b17e7e5c548108670d53ea733bc7f9.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f147f21ebee331ba4f7630cf0eefc936.webp",980,1306]